Actively Recruiting

Phase Not Applicable
Age: 1Month - 1Year
All Genders
ID06821776

N-of-1 Trial Comparing Prolonged Gastric Feeding to Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia

Led by Le Bonheur Children's Hospital · Updated on 2025-02-12

25

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating feeding methods for hospitalized infants with severe bronchopulmonary dysplasia (BPD) who also have feeding intolerance. This study aims to determine the best feeding approach by comparing continuous gastric feeding with continuous transpyloric feeding. The trial is designed as a randomized crossover study to assess respiratory status and identify the optimal feeding mode for each infant. Infants will receive two weeks of continuous gastric feeding through a tube placed in the stomach, followed by two weeks of continuous transpyloric feeding where the tube passes through the stomach into the small intestine. Each infant will experience both feeding methods in this crossover design, with a total of four weeks of feeding interventions. During the study, respiratory severity will be closely monitored using the Respiratory Severity Score over eight weeks. Participants will be assessed for respiratory status and feeding tolerance throughout the trial. The study is sponsored by Le Bonheur Children's Hospital and involves infants born before 32 weeks gestation currently admitted to the neonatal intensive care unit (NICU).

CONDITIONS

Brief Title

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

Who Can Participate

Age: 1Month - 1Year
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients born <32 weeks' gestation
  • Currently admitted to the Le Bonheur NICU
  • Grade 2 or 3 bronchopulmonary dysplasia (positive pressure or intubated at 36 weeks postmenstrual age)
  • Signs of gastroesophageal reflux, chronic aspiration, or other feeding intolerance
Not Eligible

You will not qualify if you...

  • Known gastrointestinal anomalies
  • Unable to tolerate 60mL/kg/day enteral feeding
  • Congenital anomalies likely to alter feeding techniques
  • Surgical feeding tube in place or expected within the next 8 weeks
  • Expected to remain hospitalized less than 8 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 4 weeks

Participants receive two feeding methods in a randomized order: gastric feeding and transpyloric feeding, each for 2 weeks.

2 feeding periods of 2 weeks each

Trial Site Locations

Total: 1 location

1

Le Bonheur Children's Hospital

Memphis, Tennessee, United States, 38103

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

A Phase 2b Study Evaluating OHB-607 Compared to Standard Neo...

Bronchopulmonary Dysplasia

Actively Recruiting

66 locations

Crossover Study of Work of Breathing With Different BiPAP Pr...

Bronchopulmonary Dysplasia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Transpyloric feeding is associated with adverse in-hospital outcomes in infants with severe bronchopulmonary dysplasia.

Jonathan C Levin, Matthew J Kielt, Lystra P Hayden...

https://pubmed.ncbi.nlm.nih.gov/38218908

Individualising care in severe bronchopulmonary dysplasia: a series of N-of-1 trials comparing transpyloric and gastric feeding.

Erik A Jensen, Huayan Zhang, Rui Feng...

https://pubmed.ncbi.nlm.nih.gov/31685527